Gonadotropin-releasing hormone-agonist induces apoptosis of human granulosa-luteal cells via caspase-8, -9 and -3, and poly-(ADP-ribose)-polymerase cleavage

BioScience Trends

Volumn 5, Issue 3, 2011, Pages 120-128

  Park, Eun Joo ^a   Shin, Jung Whan ^a   Seo, Yong Soo ^a   Kim, Dae Wun ^a   Hong, Seo Yoo ^a   Park, Won Il ^a   Kang, Byung Moon ^b  

^a Eulji University School of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Apoptosis; Caspase; Gonadotropin releasing hormoneagonist; Human granulosa luteal cells; Poly (ADP ribose) polymerase

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; GONADORELIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CELL CULTURE; CYTOLOGY; DNA FRAGMENTATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FERTILIZATION IN VITRO; HUMAN; LUTEAL CELL; METABOLISM; NICK END LABELING; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CASPASE 9; CELLS, CULTURED; DNA FRAGMENTATION; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; IN SITU NICK-END LABELING; LUTEAL CELLS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84863115563     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2011.v5.3.120     Document Type: Article

References (42)

1. Barbieri RL, Hornstein HD. Assisted reproductionin vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues. Endocr Rev. 1999; 20:249-252.
2. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Bustion S, Loumaye E, Fauser BC. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab. 2003; 88:4186-4192.
3. Sifer C, Blanc-Layrac G, Bringuier AF, Porcher R, Madelenat P, Feldmann G, Benifla JL. Effects of a gonadotropin-releasing hormone agonist and follicle stimulating hormone on the incidence of apoptosis in human luteinized granulosa cells. Eur J Obstet Gynecol Reprod Biol. 2003; 110:43-48.
4. Peng C, Fan NC, Ligier M, Väänänen J, Leung PC. Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology. 1994; 135:1740-1746.
5. Minaretzis D, Jakubowski M, Mortola JF, Pavlou SN. Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. J Clin Endocrinol Metab. 1995; 80:430-434.
6. Fraser HM, Sellar RE, Illingworth PJ, Eidne KA. GnRH receptor mRNA expression by in situ hybridization in the primate pituitary and ovary. Mol Hum Reprod. 1996; 2:117-121.
7. Parborell F, Dain L, Tesone M. Gonadotropin-releasing hormone agonist affects rat ovarian follicle development by interfering with FSH and growth factors on the prevention of apoptosis. Mol Reprod Dev. 2001; 60:241-247.
8. Hong IS, Cheung AP, Leung PC. Gonadotropin-releasing hormones I and II induce apoptosis in human granulosa cells. J Clin Endocrinol Metab. 2008; 93:3179-3185.
9. Parborell F, Pecci A, Gonzalez O, Vitale A, Tesone M. Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: Regulation by epidermal growth factor and the expression of Bcl-2-related genes. Biol Reprod. 2002; 67:481-486.
10. Abramovich D, Parborell F, Tesone M. Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats. Biol Reprod. 2006; 75:434-441.
11. Yang H, Bhat GK, Wadley R, Wright KL, Chung BM, Whittaker JA, Dharmarajan AM, Sridaran R. Gonadotropin-releasing hormone-agonist inhibits synthesis of nitric oxide and steroidogenesis by luteal cells in the pregnant rat. Biol Reprod. 2003; 68:2222-2231.
12. Alnemri ES. Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases. J Cell Biochem. 1997; 64:33-42.
13. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADDinteracting protease, in Fas/APO-1- and TNF receptorinduced cell death. Cell. 1996; 85:803-815.
14. Lim ML, Lum MG, Hansen TM, Roucou X, Nagley P. On the release of cytochrome c from mitochondria during cell death signaling. J Biomed Sci. 2002; 9:488-506.
15. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng SL, Fesik SW. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 1996; 381:335-341.
16. Minn AJ, Vélez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill M, Thompson CB. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature. 1997; 385:353-357.
17. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATPdependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997; 91:479-489.
18. Soldani C, Scovassi AI. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update. Apoptosis. 2002; 7:321-328.
19. Komoriya A, Packard BZ, Brown MJ, Wu ML, Henkart PA. Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J Exp Med. 2000; 191:1819-1828.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227:680-685.
21. Towbin H, Staehelin T, Gordon J. Elcetrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci U S A. 1979; 76:4350-4354.
22. Vitale AM, Abramovich D, Peluffo MC, Meresman G, Tesone M. Effect of gonadotropin-releasing hormone agonist and antagonist on proliferation and apoptosis of human luteinized granulosa cells. Fertil Steril. 2006; 85:1064-1067.
23. Wyllie AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol. 1980; 68:251-306.
24. Takekida S, Matsuo H, Maruo T. GnRH agonist action on granulosa cells at varying follicular stages. Mol Cell Endocrinol. 2003; 202:155-164.
25. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26:239-257.
26. 2+-dependent endonuclease activity in rat granulosa and luteal cells. Endocrinology. 1989; 125:2218-2220.
27. Wang J, Steele GL, Baimbridge KG, Rodway MR, Leung PC. Intracellular calcium and the signaling mechanism of luteinizing hormone-releasing hormone in rat granulosa cells. Am J Obstet Gynecol. 1992; 167:541-547.
28. Matsumi H, Yano T, Osuga Y, Kugu K, Tang X, Xu JP, Yano N, Kurashima Y, Ogura T, Tsutsumi O, Koji T, Esumi H, Taketani Y. Regulation of nitric oxide synthase to promote cytostasis in ovarian follicular development. Bio Reprod. 2000; 63:141-146.
29. Matsumi H, Koji T, Yano T, Yano N, Tsutsumi O, Momoeda M, Osuga Y, Taketani Y. Evidence for an inverse relationship between apoptosis and inducible nitric oxide synthesis expression in rat granulosa cells: A possible role of nitric oxide in ovarian follicle atresia. Endocr J. 1998; 45:745-751.
30. Chun SY, Billig H, Tilly J, Furuta I, Tsafriri A, Hsueh AJ. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: Mediatory role of endogeneous insulin-like growth factor I. Endocrinology. 1994; 135:1845-1853.
31. Kumar S. ICE-like proteases in apoptosis. Trends Biochem Sci. 1995; 20:198-202.
32. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell. 1997; 91:443-446.
33. Chowdhury I, Tharakan B, Bhat GK. Caspases - an update. Comp Biochem Physiol B Biochem Mol Biol. 2008; 151:10-27.
34. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science. 1998; 281:1305-1308.
35. Wang L, Du F, Wang X. TNF-α induces two distinct caspase-8 activation pathways. Cell. 2008; 133:693-703.
36. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell. 1996; 86:147-157.
37. Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998; 12:1551-1570.
38. Adams JM. Ways of dying: Multiple pathways to apoptosis. Genes Dev. 2003; 17:2481-2495.
39. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995; 81:801-809.
40. Rodríguez-Hernández A, Brea-Calvo G, Fernández-Ayala DJ, Cordero M, Navas P, Sánchez-Alcázar JA. Nuclear caspase-3 and caspase-7 activation, and poly(ADP-ribose) polymerase cleavage are early events in camptothecin-induced apoptosis. Apoptosis. 2006; 11:131-139.
41. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998; 391:43-50.
42. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science. 1997; 278:294-298.